ASIX

AdvanSix Inc.

Fundamental data last updated:June 10, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Chemicals

Exchange

NYSE

County of HQ

US

Next Earnings Date

07/31/2026

Business Summary

AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.

 


Analyze ASIX on TradingView

VALUATION

P/E

59.85

Market Cap ($M USD)

$621.67M

Forward P/E

8.09

PEG

0.01

PRICE TO SALES

0.40

PRICE TO BOOK

0.78

EV / EBITDA

10.91

5-Year Average P/E

Free Cash Flow Yield

-3.58%

DCF Value

$33.79

Graham Number

$16.00

Price to FCF

-27.96

EV to FCF

-46.35

Earnings Yield

1.67%

FCF Yield

-3.58%

DIVIDEND

Yield

2.78%

Annual Payout

$0.64

Payout Ratio

165.44%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$0.39

Next Year EPS Growth Estimate

$2.85

Next Year Revenue Growth Estimate

$177.40B

Return on Equity (ROE)

1.28%

FREE CASH FLOW

Operating Margin

0.74%

Debt-to-Equity

0.47

Piotroski F-Score

5

Altman Z-Score

1.91

Return on Invested Capital (ROIC)

0.85%

Current Ratio

1.23

Quick Ratio

0.68

Net Debt to EBITDA

4.33

Interest Coverage

1.22

Gross Profit margin

7.44%

FCF PER SHARE

$-0.82

REVENUE PER SHARE

$57.40

Analyze ASIX on TradingView

Gainseekers Quantitative Analysis

Summary

ASIX appears to be a classic deep value play, with its market price significantly below the DCF value and Graham Number. The Forward P/E of 7.13 suggests the market is pricing in a conservative growth outlook, despite a robust earnings estimate for next year. However, the Altman Z-score of 1.91 raises red flags about financial distress risk. The earnings yield of 1.90% is underwhelming, indicating the stock may not be offering enough return relative to its risk. Overall, the market seems to be underestimating its intrinsic value, but caution is warranted given the financial health indicators.

AI Exposure / Tech Reliance

Operating in the Chemicals industry, ASIX is not directly tied to AI or tech advancements. However, its sector could benefit from AI-driven efficiencies in production processes. The company must leverage tech to optimize operations and maintain competitiveness.

The Bull Case

For the value-driven investor, ASIX offers compelling reasons to buy. The ROIC of 2.46% and a Piotroski F-Score of 5 suggest moderate operational efficiency and financial health. Despite a low FCF yield of 2.51%, the company's operating margin of 2.13% indicates some pricing power. These metrics hint at a potential for capital efficiency improvements, making it an attractive target for those seeking undervalued opportunities.

The Bear Case

The bear case for ASIX is hard to ignore. The Price/Book ratio of 0.69 and Price/Sales ratio of 0.35 suggest undervaluation, but the EV to EBITDA of 10.12 indicates a premium valuation relative to earnings. The payout ratio of 165.44% is unsustainable, raising concerns about dividend safety. Additionally, the net debt to EBITDA ratio of 4.33 highlights significant leverage, posing a risk in volatile markets.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$22.00

Institutional Ownership %

1-Year Beta

1.33

Insider Buying % (6 Mo)

Distance to 52-Week High

15.92%

Distance to 52-Week Low

38.86%

EARNINGS SURPRISE %

-5.26%

50-DAY SMA

$23.17

200-DAY SMA

$19.58

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.